HIV Stocks List

Related ETFs - A few ETFs which own one or more of the above listed HIV stocks.

HIV Stocks Recent News

Date Stock Title
Apr 27 GILD Gilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Apr 26 LH Integer Holdings (ITGR) Q1 Earnings Top Estimates, Margins Up
Apr 26 LH 3 Medical Products Stocks Set to Beat This Earnings Season
Apr 26 GILD Gilead Sciences declares $0.77 dividend
Apr 26 GILD Gilead (GILD) Q1 Loss Narrower Than Expected, Sales Beat
Apr 26 GILD Q1 2024 Gilead Sciences Inc Earnings Call
Apr 26 GILD FDA Approves Biktarvy® Label Update With Data for Pregnant Adults With HIV
Apr 26 LH Laboratory Corporation of America Holdings First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
Apr 26 GILD Gilead Sciences Inc (GILD) Q1 2024 Earnings Call Transcript Highlights: Key Financials and ...
Apr 26 LH Q1 2024 Laboratory Corporation of America Holdings Earnings Call
Apr 26 GILD Gilead Sciences (GILD) Q1 2024 Earnings Call Transcript
Apr 26 GILD Gilead Sciences, Inc. (GILD) Q1 2024 Earnings Call Transcript
Apr 26 GILD Gilead Sciences, Inc. 2024 Q1 - Results - Earnings Call Presentation
Apr 25 GILD Gilead has strong Q1, but updated 2024 EPS guidance range misses consensus
Apr 25 GILD Gilead (GILD) Reports Q1 Earnings: What Key Metrics Have to Say
Apr 25 GILD Gilead Beats Earnings Expectations After Rocky Quarter
Apr 25 GILD Gilead Sciences Inc (GILD) Q1 2024 Earnings: Misses Analyst EPS Estimates Amid Significant ...
Apr 25 GILD Gilead Sciences (GILD) Reports Q1 Loss, Tops Revenue Estimates
Apr 25 GILD Gilead Notches A Quarterly Beat On The Back Of Its Covid Drug, Again
Apr 25 GILD Gilead Sciences in charts: Revenue from oncology rises most among products; Veklury dips in Q1
HIV

The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and over time acquired immunodeficiency syndrome (AIDS). AIDS is a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. Without treatment, average survival time after infection with HIV is estimated to be 9 to 11 years, depending on the HIV subtype. In most cases, HIV is a sexually transmitted infection and occurs by contact with or transfer of blood, pre-ejaculate, semen, and vaginal fluids. Non-sexual transmission can occur from an infected mother to her infant during pregnancy, during childbirth by exposure to her blood or vaginal fluid, and through breast milk. Within these bodily fluids, HIV is present as both free virus particles and virus within infected immune cells.
HIV infects vital cells in the human immune system, such as helper T cells (specifically CD4+ T cells), macrophages, and dendritic cells. HIV infection leads to low levels of CD4+ T cells through a number of mechanisms, including pyroptosis of abortively infected T cells, apoptosis of uninfected bystander cells, direct viral killing of infected cells, and killing of infected CD4+ T cells by CD8+ cytotoxic lymphocytes that recognize infected cells. When CD4+ T cell numbers decline below a critical level, cell-mediated immunity is lost, and the body becomes progressively more susceptible to opportunistic infections, leading to the development of AIDS.

Browse All Tags